|

TKI Clinical Trials

2 actively recruiting trials

Also known as: Cohort 5 (ACC-TKI)

Pipeline

Phase 2: 2

Top Sponsors

  • Tata Memorial Hospital1
  • Peking Union Medical College1

Indications

  • Cancer2
  • Driver Mutation1
  • Precision Therapy1
  • Oligometastatic Disease1
  • Salivary Gland Carcinoma1

Other2 trials

Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
Phase 2
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.